[HTML][HTML] Molecular pathways in prolactinomas: Translational and therapeutic implications
B Biagetti, R Simò - International Journal of Molecular Sciences, 2021 - mdpi.com
Prolactinoma has the highest incidence rate among patients with functional pituitary
tumours. Although mostly benign, there is a subgroup that can be aggressive. Some clinical …
tumours. Although mostly benign, there is a subgroup that can be aggressive. Some clinical …
Molecular Pathways in Prolactinomas: Translational and Therapeutic Implications
B Biagetti, R Simò - 2021 - agris.fao.org
Prolactinoma has the highest incidence rate among patients with functional pituitary
tumours. Although mostly benign, there is a subgroup that can be aggressive. Some clinical …
tumours. Although mostly benign, there is a subgroup that can be aggressive. Some clinical …
Molecular Pathways in Prolactinomas: Translational and Therapeutic Implications
B Biagetti, R Simò - International Journal of Molecular …, 2021 - search.proquest.com
Prolactinoma has the highest incidence rate among patients with functional pituitary
tumours. Although mostly benign, there is a subgroup that can be aggressive. Some clinical …
tumours. Although mostly benign, there is a subgroup that can be aggressive. Some clinical …
[HTML][HTML] Molecular Pathways in Prolactinomas: Translational and Therapeutic Implications
B Biagetti, R Simò - International Journal of Molecular Sciences, 2021 - ncbi.nlm.nih.gov
Prolactinoma has the highest incidence rate among patients with functional pituitary
tumours. Although mostly benign, there is a subgroup that can be aggressive. Some clinical …
tumours. Although mostly benign, there is a subgroup that can be aggressive. Some clinical …
Molecular Pathways in Prolactinomas: Translational and Therapeutic Implications.
B Biagetti, R Simò - International Journal of Molecular …, 2021 - search.ebscohost.com
Prolactinoma has the highest incidence rate among patients with functional pituitary
tumours. Although mostly benign, there is a subgroup that can be aggressive. Some clinical …
tumours. Although mostly benign, there is a subgroup that can be aggressive. Some clinical …
Molecular Pathways in Prolactinomas: Translational and Therapeutic Implications
B Biagetti, R Simò - International journal of molecular …, 2021 - pubmed.ncbi.nlm.nih.gov
Prolactinoma has the highest incidence rate among patients with functional pituitary
tumours. Although mostly benign, there is a subgroup that can be aggressive. Some clinical …
tumours. Although mostly benign, there is a subgroup that can be aggressive. Some clinical …
Molecular Pathways in Prolactinomas: Translational and Therapeutic Implications.
B Biagetti, R Simò - International Journal of Molecular Sciences, 2021 - europepmc.org
Prolactinoma has the highest incidence rate among patients with functional pituitary
tumours. Although mostly benign, there is a subgroup that can be aggressive. Some clinical …
tumours. Although mostly benign, there is a subgroup that can be aggressive. Some clinical …